1. Home
  2. ASMB vs ORMP Comparison

ASMB vs ORMP Comparison

Compare ASMB & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ORMP
  • Stock Information
  • Founded
  • ASMB 2005
  • ORMP 2002
  • Country
  • ASMB United States
  • ORMP United States
  • Employees
  • ASMB N/A
  • ORMP N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASMB Health Care
  • ORMP Health Care
  • Exchange
  • ASMB Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • ASMB 84.5M
  • ORMP 90.7M
  • IPO Year
  • ASMB 2010
  • ORMP N/A
  • Fundamental
  • Price
  • ASMB $12.57
  • ORMP $2.47
  • Analyst Decision
  • ASMB Buy
  • ORMP Hold
  • Analyst Count
  • ASMB 2
  • ORMP 1
  • Target Price
  • ASMB $35.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • ASMB 21.7K
  • ORMP 435.6K
  • Earning Date
  • ASMB 03-27-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • ASMB N/A
  • ORMP N/A
  • EPS Growth
  • ASMB N/A
  • ORMP N/A
  • EPS
  • ASMB N/A
  • ORMP 0.11
  • Revenue
  • ASMB $28,326,000.00
  • ORMP N/A
  • Revenue This Year
  • ASMB $282.16
  • ORMP N/A
  • Revenue Next Year
  • ASMB N/A
  • ORMP N/A
  • P/E Ratio
  • ASMB N/A
  • ORMP $22.57
  • Revenue Growth
  • ASMB N/A
  • ORMP N/A
  • 52 Week Low
  • ASMB $11.01
  • ORMP $2.00
  • 52 Week High
  • ASMB $19.93
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 34.21
  • ORMP 60.22
  • Support Level
  • ASMB $13.60
  • ORMP $2.16
  • Resistance Level
  • ASMB $14.25
  • ORMP $3.09
  • Average True Range (ATR)
  • ASMB 0.57
  • ORMP 0.14
  • MACD
  • ASMB -0.11
  • ORMP 0.03
  • Stochastic Oscillator
  • ASMB 3.02
  • ORMP 36.08

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: